
Labiana Health S.A (LAB) | Financial Analysis & Statements
Labiana Health S.A. | Small-cap | Healthcare
Labiana Health S.A. | Small-cap | Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Sep 2022Income Metrics
Revenue
10.6M
Gross Profit
15.6M
147.79%
Operating Income
9.1M
85.72%
Net Income
7.0M
66.63%
EPS (Diluted)
€0.02
Balance Sheet Metrics
Total Assets
60.8M
Total Liabilities
53.9M
Shareholders Equity
6.9M
Debt to Equity
7.80
Cash Flow Metrics
Operating Cash Flow
-7.2M
Free Cash Flow
-2.2M
Revenue & Profitability Trend
Labiana Health S.A Income Statement From 2020 to 2023
Metric | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|
Revenue | 58.5M | 57.8M | 57.0M | 57.8M |
Cost of Goods Sold | 24.1M | 25.2M | 22.0M | 23.8M |
Gross Profit | 34.3M | 32.6M | 35.0M | 34.0M |
Gross Margin % | 58.7% | 56.4% | 61.4% | 58.8% |
Operating Expenses | ||||
Research & Development | - | - | - | - |
Selling, General & Administrative | - | 11.2M | 11.2M | 11.1M |
Other Operating Expenses | 12.0M | 11.7M | 11.7M | 11.7M |
Total Operating Expenses | 12.0M | 22.9M | 22.9M | 22.8M |
Operating Income | -1.8M | -2.4M | 653.9K | 2.5M |
Operating Margin % | -3.2% | -4.1% | 1.1% | 4.3% |
Non-Operating Items | ||||
Interest Income | 5.3K | 624.1K | 133.7K | 5.6K |
Interest Expense | 3.3M | 2.1M | 2.1M | 1.9M |
Other Non-Operating Income | - | - | - | - |
Pre-tax Income | -5.3M | -7.8M | -2.1M | 541.2K |
Income Tax | -776.0K | 1.3M | -13.3K | -532.5K |
Effective Tax Rate % | 0.0% | 0.0% | 0.0% | -98.4% |
Net Income | -4.5M | -9.1M | -2.1M | 1.1M |
Net Margin % | -7.7% | -15.7% | -3.7% | 1.9% |
Key Metrics | ||||
EBITDA | 3.3M | 3.0M | 5.1M | 5.4M |
EPS (Basic) | - | - | €-0.25 | €0.15 |
EPS (Diluted) | - | - | €-0.25 | €0.15 |
Basic Shares Outstanding | - | - | 7221255 | 7221255 |
Diluted Shares Outstanding | - | - | 7221255 | 7221255 |
Income Statement Trend
Labiana Health S.A Balance Sheet From 2019 to 2023
Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 3.0M | 2.5M | 3.3M | 1.5M | 41.2M |
Short-term Investments | 13.9K | 9.1K | 11.4K | 868.5K | 1.5M |
Accounts Receivable | 11.8M | 8.8M | 7.9M | 10.5M | 4.8M |
Inventory | 11.1M | 12.7M | 14.9M | 14.1M | 35.1M |
Other Current Assets | 0 | - | - | - | 971.0K |
Total Current Assets | 29.0M | 28.8M | 29.4M | 29.3M | 117.6M |
Non-Current Assets | |||||
Property, Plant & Equipment | 1.3M | 1.2M | 1.1M | 1.1M | 12.0M |
Goodwill | 7.7M | 9.0M | 14.0M | 12.6M | 458.8M |
Intangible Assets | 7.7M | 9.0M | 11.5M | 11.4M | 81.3M |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | - | 0 | 0 | - | 1.0M |
Total Non-Current Assets | 30.1M | 32.0M | 39.0M | 36.7M | 344.7M |
Total Assets | 59.1M | 60.8M | 68.4M | 66.0M | 462.4M |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 8.8M | 11.3M | 8.6M | 9.0M | 20.1M |
Short-term Debt | 11.1M | 20.0M | 19.4M | 9.2M | 507.0K |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | - | - | - | 0 | - |
Total Current Liabilities | 24.7M | 35.1M | 30.5M | 20.8M | 20.7M |
Non-Current Liabilities | |||||
Long-term Debt | 30.6M | 18.2M | 25.3M | 29.5M | 51.7M |
Deferred Tax Liabilities | 357.4K | 399.3K | 322.9K | 545.7K | 5.4M |
Other Non-Current Liabilities | 0 | 0 | - | - | - |
Total Non-Current Liabilities | 31.0M | 18.8M | 26.4M | 30.9M | 51.7M |
Total Liabilities | 55.7M | 53.9M | 56.8M | 51.7M | 72.4M |
Equity | |||||
Common Stock | 722.1K | 722.1K | 618.8K | 618.8K | 371.7M |
Retained Earnings | -4.4M | -8.9M | -1.8M | 1.1M | -67.8M |
Treasury Stock | 200.1K | 294.7K | 0 | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 3.4M | 6.9M | 11.5M | 14.3M | 348.6M |
Key Metrics | |||||
Total Debt | 41.7M | 38.2M | 44.8M | 38.6M | 52.2M |
Working Capital | 4.3M | -6.3M | -1.0M | 8.5M | 96.9M |
Balance Sheet Composition
Labiana Health S.A Cash Flow Statement From 2020 to 2023
Metric | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|
Operating Activities | ||||
Net Income | -5.3M | -7.8M | -2.1M | 541.2K |
Depreciation & Amortization | - | - | - | - |
Stock-Based Compensation | - | - | - | - |
Working Capital Changes | 387.5K | 44.2K | 2.3M | -1.1M |
Operating Cash Flow | -1.7M | -5.7M | 2.2M | 1.4M |
Investing Activities | ||||
Capital Expenditures | -1.6M | -2.8M | -2.3M | -4.2M |
Acquisitions | - | 0 | 2.4M | -593.3K |
Investment Purchases | -65.0K | -932.7K | -3.7M | 0 |
Investment Sales | 556.4K | 3.4M | 0 | - |
Investing Cash Flow | -1.2M | -274.6K | -4.8M | -4.8M |
Financing Activities | ||||
Share Repurchases | -158.6K | -412.1K | -1.1M | 0 |
Dividends Paid | - | - | - | - |
Debt Issuance | 19.5M | 736.7K | 1.8M | 4.6M |
Debt Repayment | -16.3M | -7.4M | 0 | - |
Financing Cash Flow | 4.3M | -5.6M | 5.1M | 2.9M |
Free Cash Flow | -4.7M | -774.4K | -858.7K | -2.9M |
Net Change in Cash | 1.5M | -11.6M | 2.5M | -457.7K |
Cash Flow Trend
Labiana Health S.A Key Financial Ratios
Valuation Ratios
Forward P/E
4.33
Price to Book
5.80
Price to Sales
0.41
Profitability Ratios
Profit Margin
0.38%
Operating Margin
3.32%
Return on Equity
6.92%
Return on Assets
5.72%
Financial Health
Current Ratio
1.30
Debt to Equity
1,378.08
Beta
-0.44
Per Share Data
EPS (TTM)
€-0.16
Book Value per Share
€0.67
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
lab | 27.9M | - | 5.80 | 6.92% | 0.38% | 1,378.08 |
Laboratorios | 2.7B | 20.56 | 4.83 | 25.01% | 17.66% | 22.50 |
Almirall S.A | 2.2B | 102.60 | 1.51 | 1.45% | 2.02% | 26.47 |
Faes Farma S.A | 1.3B | 12.41 | 1.80 | 14.83% | 19.37% | 11.48 |
Laboratorio Reig | 240.1M | 42.14 | 1.10 | 3.03% | 1.89% | 31.04 |
Grifols, S.A | 7.8B | 29.19 | 1.69 | 4.99% | 4.00% | 126.87 |
Financial data is updated regularly. All figures are in the company's reporting currency.